| Net loss | -25.7M |
| Depreciation and amortization | 309K |
| Stock-based compensation | 2.02M |
| Accounts receivable | 973K |
| Inventories | -366K |
| Prepaid expenses and other assets | 1.4M |
| Accounts payable | 208K |
| Accrued and other liabilities | 583K |
| Contract research liability | -20K |
| Deferred revenue | 92K |
| Total adjustments | 5.77M |
| Net cash (used in) provided by operating activities | |
| Purchases of property and equipment | -33K |
| Purchases of available-for-sale securities | -24.49M |
| Proceeds from maturities of available-for-sale securities | 26.73M |
| Proceeds from sales of available-for-sale securities | |
| Net cash provided by (used in) investing activities | |
| Payments on equipment financing obligations | -16K |
| Net proceeds from issuances of common stock | 20.57M |
| Net cash provided by financing activities | |
| Net (decrease) increase in cash and cash equivalents | |
| Cash and cash equivalents, beginning of the period | 3.58M |
| Cash and cash equivalents, end of the period | 5.36M |